CD33 CAR-T cell therapy (functionally optimized)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CD33 CAR-T cell therapy (functionally optimized), covering 2026-04-23 to 2026-04-23. Get the full timeline:
Most recent: Clinical Trial Update: Functionally Optimized CD33 CAR-T Cell Therapy Targeting Recurrent/Refractory Acute Myeloid Leukemia [Phase 1]